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Abstract
Background: Human immunodeficiency virus type one (HIV-1) is the major pathogen that causes the acquired
immune deficiency syndrome (AIDS). With the availability of large-scale protein-protein interaction (PPI)
measurements, comparative network analysis can provide a promising way to study the host-virus interactions
and their functional significance in the pathogenesis of AIDS. Until now, there have been a large number of HIV
studies based on various animal models. In this paper, we present a novel framework for studying the host-HIV
interactions through comparative network analysis across different species.
Results: Based on the proposed framework, we test our hypothesis that HIV-1 attacks essential biological
pathways that are conserved across species. We selected the Homo sapiens and Mus musculus PPI networks
with the largest coverage among the PPI networks that are available from public databases. By using a local
network alignment algorithm based on hidden Markov models (HMMs), we first identified the pathways that are
conserved in both networks. Next, we analyzed the HIV-1 susceptibility of these pathways, in comparison with
random pathways in the human PPI network. Our analysis shows that the conserved pathways have a
significantly higher probability of being intercepted by HIV-1. Furthermore, Gene Ontology (GO) enrichment
analysis shows that most of the enriched GO terms are related to signal transduction, which has been
conjectured to be one of the major mechanisms targeted by HIV-1 for the takeover of the host cell.
1
Conclusions: This proof-of-concept study clearly shows that the comparative analysis of PPI networks across
different species can provide important insights into the host-HIV interactions and the detailed mechanisms of
HIV-1. We expect that comparative multiple network analysis of various species that have different levels of
susceptibility to similar lentiviruses may provide a very effective framework for generating novel, and
experimentally verifiable, hypotheses on the mechanisms of HIV-1. We believe that the proposed framework has
the potential to expedite the elucidation of the important mechanisms of HIV-1, and ultimately, the discovery of
novel anti-HIV drugs.
Background
Acquired immune deficiency syndrome (AIDS), one of the most destructive pandemics in recorded history
according to the statistics from the World Health Organization (WHO) [1], has killed more than 25 million
people since it was first recognized in 1981. Human immunodeficiency virus type one (HIV-1) has been
found to be the causative pathogen of AIDS [2,3]. HIV-1 is a lentivirus, a slow retrovirus that is
responsible for long-duration illness with a long incubation period. HIV-1 has 9 genes which encode up to
19 proteins due to post-translational cleavage [4]. By reverse transcription from viral RNA to
host-integrable DNA, the virus can become active and replicate to cause rapid T cell depletion, immune
system collapse, and opportunistic infections that mark the advent of AIDS [5].
Although advances in antiviral therapy and management of opportunistic infection for AIDS have
remarkably improved the general health, the expensive cost and adverse effects of the available drugs have
motivated many researchers to explore novel avenues to anti-HIV-1 drug discovery. With the increasing
coverage of HIV-1 and human protein interactions in the literature [6–11], a human/HIV-1 interactome has
been created [12], which can play a critical role in better understanding the virology and pathology of this
infectious disease and developing new therapeutics. In addition to this, the availability of large-scale
biological networks, including protein-protein interaction (PPI) networks, has led to the introduction of
systems biology approaches for novel HIV-1 drug discovery [13,14]. In [13], Balakrishnan et al. proposed to
find alternative pathways to circumvent the HIV-1 intercepted pathways based on the efficiency and
robustness of biological processes. The main goal was to generate new hypotheses regarding HIV-1
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targeted pathways and their effects on various molecular functions, which will help us better understand
the mechanisms of HIV-1 takeover of the host cell and find ways to circumvent it. The study was based on
curated signal transduction pathways obtained from multiple pathway databases. One practical problem of
this pathway-based approach is that the currently known pathways cover only a limited number of human
proteins, hence it may exclude important HIV-1 targets from the analysis. Moreover, many curated
pathways in public databases overlap with each other, which may introduce bias in the analysis. On the
other hand, Lin et al. [14] proposed comparative studies of host-virus protein interactions across human
(Homo sapiens) and other animal models that may be invaded by similar lentiviruses that cause
immunosuppression or immunoproliferation, including three mammalian species: chimpanzee (Pan
troglodyte), rhesus macaque (Macaca mulatta), and mouse (Mus musculus). All these animal models have
been extensively studied to understand the HIV-1 host-virus interplay [15,16]. Comparative studies of
host-virus interactions may provide new insights into why different species have different susceptibility to
HIV-1, which may lead to the development of potential therapeutics in the long run.
Motivated by these works, we propose a novel framework for studying human/HIV-1 interactions, based on
comparative analysis of the human PPI network and the PPI network of other species that are susceptible
to lentivirus invasion. It has been shown that the comparative analysis of PPI networks of different species
can identify conserved pathways that carry essential cellular functionalities [17–36]. Furthermore, HIV-1
has to be a “minimalist” in order to survive, and for this reason, it has been believed to target these
essential pathways that are conserved across species [13,37]. As a result, the comparative analysis of PPI
networks may be used to generate new hypotheses that will be useful in improving our understanding of
the mechanisms of HIV-1 takeover of the host cell, and ultimately, for developing effective therapeutics for
AIDS.
Results and Discussion
Conserved pathways are susceptible to HIV-1 attacks
Our main goal in this paper is to validate the following hypothesis:
“Essential biological pathways that are conserved across different species that are susceptible to lentiviruses,
have a high probability of being intercepted by HIV-1.”
To validate the above hypothesis, we first aligned the Homo sapiens PPI network with the Mus musculus
PPI network to find conserved pathways (Figure 1). The Mus musculus network was chosen as it is the
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Figure 1: Overview of the proposed approach: (A) Illustration of the Homo sapiens and Mus musculus PPI
networks along with HIV-1 interactions. The dashed line that connects two nodes ui and vj indicate that the
corresponding proteins are orthologous. The solid lines represent protein-protein interactions. In the Homo
sapiens network, the proteins are colored based on the HIV-1 proteins that can bind to them. Proteins
with multiple colors are susceptible to multiple HIV-1 proteins, while proteins with no color have no known
interactions with HIV-1 proteins. Note that the Mus musculus network is not colored. (B) The top-scoring
alignment between two similar paths u and v. Colored nodes represent matched proteins. (C) An example
of a randomly extracted pathway in the Homo sapiens network.
largest animal network under lentivirus study that is available from public databases. This will allow us to
reduce the bias that may arise from using smaller networks. For identifying conserved pathways, we used a
local network alignment method based on hidden Markov models (HMMs), which we recently proposed
in [36]. The HMM framework can naturally integrate both the “sequence similarity” of the proteins across
different species and the “interaction reliability” between the proteins within the same PPI network into
the scoring scheme for finding conserved pathways. The HMM-based local alignment method allows flexible
number of consecutive insertions and/or deletions, and it can deal with a large class of path isomorphism.
More importantly, the computational complexity for finding the best matching pathways grows linearly
with respect to the size of each network, making it suitable for finding long conserved pathways in large
PPI networks. We ran the HMM-based local alignment algorithm to find conserved pathways both with
and without gaps. Since the Mus musculus network is still quite sparse (see Methods), the number of
conserved pathways depends on whether we allow gaps and how long the pathways can be. Typically, we
have fewer conserved pathways when we search for long pathways with no gaps allowed.
Next, we extracted 3, 000 random pathways of different sizes (L = 16, 32, and 64) by performing a random
walk on the Homo sapiens network (see Methods). Then we compared the HIV-1 susceptibility of the
conserved pathways with that of the random pathways in the Homo sapiens PPI network, by using the
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Figure 2: The number of proteins that interact with HIV-1 proteins in conserved pathways (with no gaps)
and randomly extracted pathways. (A) The histograms for pathways of size L = 16. (B) The histograms
for pathways of size L = 32. (C) The histograms for pathways of size L = 64.
predicted human/HIV-1 interactome map in [12].
Number of proteins in the pathways that are intercepted by HIV-1
Based on the identified conserved pathways and the randomly extracted pathways, we first computed how
many proteins within each pathway can be intercepted by HIV-1, by mapping the predicted human/HIV-1
interactions in [12] onto these pathways. Figure 2 shows the histogram of the number of HIV-1 interacting
proteins in conserved pathways as well as the histogram for random pathways. From the figure, there is a
clear distinction between the two types of histograms. Typically, the separation between the two
histograms increases with the length of the pathways. We can clearly see that highly conserved pathways
are more susceptible to HIV-1 interception, in general.
Next, we considered conserved pathways that have been identified by the HMM-based local network
alignment algorithm by allowing gaps. We compared the histograms for these pathways to the histograms
for random pathways. These results are shown in Fig. 3. We can see that the histograms show similar
trends as in Fig. 2, but the separation between the two types of histograms is smaller in this case. This
might be due to the fact that the HMM-based algorithm may find less conserved pathways when we allow
gaps.
To evaluate the statistical significance of the difference between conserved and random pathways, we
estimated the p-value of the number of HIV-1 interacting proteins for every conserved pathway. The
detailed process for computing the p-values is described in Methods. Basically, it computes the statistical
significance of the number of HIV-1 interacting proteins in each conserved pathway with respect to the
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Figure 3: The number of proteins that interact with HIV-1 proteins in conserved pathways (with gaps) and
randomly extracted pathways. (A) The histograms for pathways of size L = 16. (B) The histograms for
pathways of size L = 32. (C) The histograms for pathways of size L = 64.
baseline distribution, which is estimated from the histogram of the numbers of HIV-1 interacting proteins
in randomly extracted pathways. Figure 4(A) shows the plot of p-values for conserved pathways of various
lengths and with no gaps allowed. Conserved pathways with gaps show a similar trend (results not shown).
As we mentioned earlier, the number of conserved pathways decrease as the pathway size L gets larger. In
the figure, the conserved pathways are sorted based on their alignment scores computed by the
HMM-based local alignment method [36] (see Methods). The alignment score reflects the degree of
conservation between the aligned pathways. We can see that highly conserved pathways are generally more
susceptible to HIV-1 interception. In fact, such pathways typically contain more proteins that can be
intercepted by HIV-1 proteins.
Total number of human/HIV-1 protein interactions within one pathway
To further validate our hypothesis, we checked the total number of human/HIV-1 interactions within each
pathway. Again, we used the predicted human/HIV-1 interactome in [12] to count the total number of
human/HIV-1 interactions within each pathway. Figure 4(B) shows the p-value of the total number of
HIV-1 interactions within every conserved pathway (with no gaps). As before, the baseline distribution was
estimated using the histogram of the total numbers of HIV-1 interactions in randomly extracted pathways.
Note that, for long conserved pathways (L = 64), the p-values are always below 0.03. These results show
that the difference in susceptibility to HIV-1 interception between the conserved and random pathways is
statistically significant.
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Figure 4: Statistical significance of the interactions between HIV-1 and the conserved pathways (with no
gaps). (A) The p-values of the number of human proteins that interact with HIV-1 proteins within conserved
pathways with different sizes (L = 16: red, L = 32: blue, L = 64: green). (B) The p-values of the total
number of predicted human/HIV-1 interactions within conserved pathways. (C) The p-values for the average
predicted interaction scores within conserved pathways.
HIV-1 interaction score of conserved pathways
Finally, we evaluated the HIV-1 interaction score for conserved pathways based on the scoring scheme
in [12]. For this evaluation, we mapped the prediction scores of human/HIV-1 interactions onto the
conserved pathways and computed their average. In a similar way, we computed the average HIV-1
interaction score for each random pathway and estimated the distribution of these average scores. Then we
computed the p-values of the average prediction scores for all the conserved pathways. These p-values are
shown in Fig. 4(C) for the conserved pathways with different lengths. By comparing the results in
Fig. 4(C) and those shown in Fig. 4(A,B), we can clearly see that there exist considerable correlation
between these results. This is especially interesting, if we consider the fact that our approach does not use
any extra data except for the PPI networks, while the prediction algorithm in [12] is obtained by
integrating the information from various sources, such as gene expression, domain and motif identification,
tissue distribution, functional annotation, subcellular localization and human network features, and
HIV-1’s mimicry of human protein binding partners.
GO term enrichment analysis
We also performed a Gene Ontology (GO) term enrichment analysis [38] using GO::TermFinder [39]. We
took the top 20 conserved pathways of size L = 64 and checked their GO terms. Table 1 shows some of the
enriched GO terms, whose adjusted p-values are smaller than 2.0e− 7.1 Examples of highly enriched GO
terms include: “signaling pathway”, “signal transduction”, “cell communication”, “phosphate metabolic
1The complete enrichment analysis results can be found at http://www.cse.usf.edu/∼xqian/hiv/.
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process”, “response to stimulus”, “response to stress”, “protein modification process”, “regulation of
immune system process”, which are pathways that are widely known to be susceptible to HIV-1
interception [2, 3, 12,13]. There are also more specific GO terms that are enriched, such as “hemopoietic or
lymphoid organ development” and “lymphocyte proliferation”. Interestingly, the pathogenesis of
HIV-associated lymphomas has been conjectured to cause the complication of HIV infection as reported
in [40]. From all the proteins covered by the top 20 conserved pathways, we have listed ten human proteins
with the largest number of predicted HIV-1 interactions in Table 2. We also selected eight human proteins
that are not known to be intercepted by HIV-1, which are shown in bold face in Table 2.. We have also
listed their associated ontology keywords or GO terms based on the UniProt database.2 We note that
many of these proteins are related to the aforementioned biological processes and they might be
unidentified targets of HIV-1. Further study on these proteins may lead to a better understanding of the
biological mechanisms of HIV-1.
Results using curated human/HIV-1 protein interactions
In order to ensure that the obtained results are biologically meaningful, we further validate our hypothesis
by testing the HIV-1 susceptibility using the curated human/HIV-1 protein interaction data in the Human
Protein Interaction Database (HPID) [41]. These human/HIV-1 interactions were reported in the literature
and curated by experts and can provide another supporting evidence that pathways which are conserved
across species have a high probability of being attacked by HIV-1. As in our previous experiments, we
counted the number of HIV-1 interacting proteins in conserved pathways (without allowing gaps) and
compared it to the number of HIV-1 interacting proteins in random pathways. The resulting histograms
are shown in Fig. 5. We can see that the histograms show similar trends as in Fig. 2, but the numbers of
interacting human proteins are relatively smaller and the separation between the histograms of the
conserved pathways and the random pathways is less significant. This is expected since the HPID curated
interactions are sparser compared to the predicted interactions in [12] and smaller number of proteins in
the Homo sapiens PPI network have been mapped with the HIV-1 interactions. We have also compared
the total number of human/HIV-1 interactions in conserved pathways with that in random pathways. The
resulting histograms are shown in Fig. 6. Figure 7 plots the computed p-values of both the number of the
HIV-1 interacting proteins and the total number of human/HIV-1 interactions within every conserved
2http://www.uniprot.org/
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Table 1: Selected GO terms enriched in the top 20 conserved pathways of size L = 64 with adjusted p-values.
Gene Ontology terms Adjusted p-values
signaling pathway 1.39e-49
signaling 4.39e-47
signal transduction 1.97e-42
regulation of cellular process 1.14e-41
signal transmission 4.46e-41
signaling process 4.94e-41
regulation of biological process 1.46e-39
biological regulation 3.09e-37
intracellular signaling pathway 7.57e-37
intracellular signal transduction 2.56e-35
cell proliferation 8.71e-34
phosphate metabolic process 2.86e-33
system development 3.63e-31
enzyme linked receptor protein signaling pathway 9.49e-31
developmental process 6.77e-30
anatomical structure development 1.73e-29
organ development 2.16e-29
cell surface receptor linked signaling pathway 1.23e-28
response to endogenous stimulus 7.55e-27
cellular response to stimulus 3.96e-26
response to stimulus 4.21e-25
protein modification process 2.11e-24
regulation of metabolic process 1.12e-23
response to hormone stimulus 1.38e-21
cell communication 6.28e-21
regulation of biosynthetic process 1.55e-15
Ras protein signal transduction 2.85e-14
response to stress 1.65e-13
RNA biosynthetic process 5.10e-13
cellular macromolecule biosynthetic process 5.49e-13
regulation of transferase activity 1.15e-12
immune system development 2.09e-12
regulation of immune system process 2.26e-12
hemopoietic or lymphoid organ development 9.12e-12
hemopoiesis 4.55e-11
neurogenesis 5.75e-08
leukocyte differentiation 6.68e-08
lymphocyte proliferation 1.43e-07
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Table 2: UniProt accession numbers of selected proteins in the top 20 conserved pathways of size L = 64 with
protein names and the associated top ontology keywords and GO terms listed by http://www.uniprot.org/.
UniProt IDs Protein names Gene Ontology terms
P04637 Cellular tumor antigen p53 apoptosis; host-virus interaction;
DNA damage response;
protein tetramerization
P17612 cAMP-dependent protein kinase hormone-mediated signaling pathway;
catalytic subunit α intracellular protein kinase cascade
P28482 Mitogen-activated protein kinase 1 Ras protein signal transduction;
cell cycle; transcription;
interspecies interaction between organisms;
chemotaxis; synaptic transmission
P27361 Mitogen-activated protein kinase 3 Ras protein signal transduction;
interspecies interaction between organisms
P05412 Transcription factor AP-1 SMAD protein signal transduction;
positive regulation by host of viral transcription;
transforming growth factor (TGF) β
receptor signaling pathway
P06241 Tyrosine-protein kinase Fyn T cell receptor signaling pathway;
interspecies interaction between organisms
P06493 Cell division protein kinase 1 anti-apoptosis; cell division; mitosis
Q15796 Mothers against decapentaplegic SMAD protein complex assembly;
homolog 2 intracellular signaling pathway;
palate development; transcription;
TGF β receptor signaling pathway
P06400 Retinoblastoma-associated protein Cell cycle; Host-virus interaction;
androgen receptor signaling pathway;
myoblast differentiation
P04049 RAF proto-oncogene serine/ Ras protein signal transduction;
threonine-protein kinase cell proliferation;
protein amino acid phosphorylation
O14512 Suppressor of cytokine signaling 7 Ubl conjugation pathway;
regulation of growth; negative
regulation of signal transduction
P10721 Mast/stem cell growth factor male gonad development;
receptor transmembrane receptor protein tyrosine;
kinase signaling pathway
P15884 Transcription factor 4 cerebral cortex development;
regulation of smooth muscle cell
proliferation; transcription
P16410 Cytotoxic T-lymphocyte protein 4 immune response; negative regulation
of regulatory T cell differentiation
P29597 Non-receptor tyrosine-protein intracellular protein kinase cascade;
kinase TYK2 peptidyl-tyrosine phosphorylation
Q13480 GRB2-associated-binding protein 1 cell proliferation; epidermal growth
factor receptor signaling pathway;
insulin receptor signaling pathway
Q15503 Son of sevenless homolog 2 apoptosis; regulation of Rho protein ;
signal transduction; small GTPase
mediated signal transduction
Q96TE0 Cdk inhibitor p27KIP1 cell cycle arrest
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Figure 5: The number of proteins that interact with HIV-1 proteins based on the HPID interaction data
in conserved pathways (with no gaps) and randomly extracted pathways. (A) The histograms for pathways
of size L = 16. (B) The histograms for pathways of size L = 32. (C) The histograms for pathways of size
L = 64.
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Figure 6: The total number of human/HIV-1 protein interactions based on the HPID interaction data in
conserved pathways (with no gaps) and randomly extracted pathways. (A) The histograms for pathways
of size L = 16. (B) The histograms for pathways of size L = 32. (C) The histograms for pathways of size
L = 64.
pathway (with no gaps). Both results show that the predicted susceptibility of conserved pathways in the
Homo sapiens PPI network and the Mus musculus PPI network to HIV-1 interception is statistically
significant.
Conclusions
Local network alignment can effectively identify conserved pathways that are biologically meaningful [36].
If HIV-1 is a minimalist in order to survive and therefore targets essential pathways [13], as other viruses
do, it is natural to expect that essential pathways that are conserved across different species should be
highly vulnerable to HIV-1 attacks. Our analysis based on comparing the Homo sapiens PPI network and
the Mus musculus PPI network indicates that our conjecture is indeed true. This proof-of-concept study
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Figure 7: Statistical significance of the interactions between HIV-1 and the conserved pathways (with no
gaps) according to the curated interactions in HPID. (A) The p-values of the number of human proteins
that interact with HIV-1 proteins within conserved pathways with different sizes (L = 16: red, L = 32:
blue, L = 64: green). (B) The p-values of the total number of predicted human/HIV-1 interactions within
conserved pathways.
that we present clearly shows that the comparative network analysis of different species can provide
important insights into the mechanisms of human/HIV-1 interactions. We believe that further studies
based on aligning the networks of various species that are susceptible to similar lentiviruses will lead to
breakthroughs in HIV research. For example, although chimpanzees are the human’s closest relative in
nature, AIDS is rarely life-threatening to them [14]. Identifying the main reasons for this difference in
HIV-1 susceptibility may lead to the development of novel therapeutics for this highly destructive disease.
Balakrishnan et al. [13] proposed a heuristic way to search for alternative pathways that can circumvent
HIV-intercepted pathways, whose ultimate goal is to identify potential drug targets. In a similar way,
comparative network analysis may also be used to identify alternative pathways in the PPI network, by
querying known HIV-intercepted pathways in the human PPI network. Although comparative network
analysis is still at an early stage and is not yet as mature as comparative sequence analysis, it can take
direct advantage of the large-scale interaction measurements that have become available these days and it
has the potential to generate experimentally verifiable hypotheses on the biological mechanisms of HIV-1,
which may lead to the identification of better drug targets and innovative AIDS therapeutics in the future.
Methods
Protein-protein interaction (PPI) networks
We have obtained both the Homo sapiens and Mus musculus protein-protein interaction (PPI) networks
from the open platform NATALIE3, managed by the Knowledge Management in Bioinformatics group of the
Humboldt-Universita¨t Berlin. Both networks were obtained from several open databases [42–47] as
3https://www.mi.fu-berlin.de/wiki/pub/LiSA/Natalie/natalie-0.9.tgz
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described in [24,48]. The Homo sapiens network has 34, 979 interactions among 9, 695 proteins, and the
Mus musculus network has 3, 116 interactions among 3, 247 proteins. The similarity between proteins in
the two networks were determined based on protein sequences, protein domain information (InterPro
domains) and functional annotations (GO annotations) [48–51]. Pairs of similar proteins in the two
networks were identified based on a minimum protein identity threshold of α = 0.4 as in [24,48].
Human-HIV interaction data
As mentioned in [13], there are several types of interactions between HIV-1 proteins and human proteins,
including direct physical interactions that are reported in the literature, indirect interactions reported in
the literature, and interactions that have been manually annotated by experts [12,41]. However, many
HIV-1 virologists do not agree upon the majority of these interactions [13]. For this reason, we focus on the
human/HIV-1 interactome in [12] in our analysis, which has been computationally predicted by integrating
various types of protein features. The human/HIV-1 interactome data can be obtained from the authors’
website.4 For further validation, we also performed similar analysis based on the curated human/HIV-1
protein interactions in HPID [41].
Identification of conserved pathways through local network alignment
To align the Homo sapiens and Mus musculus PPI networks, we used the local network alignment
algorithm based on hidden Markov models (HMMs) [35,36]. Let us represent the Homo sapiens and Mus
musculus PPI networks as Gh = (U ,D) and Gm = (V, E), respectively. U = {ui} and V = {vi} represent the
sets of nodes, where each node represents a protein in a given network. D = {dij} and E = {eij} are the
sets of edges, where each edge represents the interaction between the connected proteins. For the
orthologous protein pairs in the Homo sapiens and Mus musculus PPI network that have been predicted
based on the method in [48], we define the node similarity score s(u, v) between a pair of proteins u ∈ U
and v ∈ V as follows:
s(u, v) =
{
1, if u and v are orthologous
0, otherwise. (1)
The interaction reliability scores between two nodes are binary for both PPI networks. For example, the
interaction score wh(ui, uj) between ui and uj in the Homo sapiens network is defined as:
wh(ui, uj) =
{
0, if interaction between ui and uj exists;
−∞, otherwise. (2)
4http://www.cs.cmu.edu/∼oznur/hiv/hivPPI.html
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The interaction reliability score wm(vi, vj) between vi and vj in the Mus musculus network is defined in a
similar way.
In order to find the pathways that are conserved in both PPI networks, we first search for the best matching
pair of paths u = u1u2 . . . uL (ui ∈ U) and v = v1v2 . . . vL (vi ∈ V) in the respective networks (Fig. 1) that
maximizes a predefined pathway alignment score S(u,v). The pathway alignment score S(u,v) integrates
the similarity score s(ui, vi) between the aligned nodes ui and vi (1 ≤ i ≤ L), the interaction reliability
score wh(ui, ui+1) between ui and ui+1 (1 ≤ i ≤ L− 1), the interaction reliability score wm(vj , vj+1)
between vj and vj+1 (1 ≤ j ≤ L− 1), and the penalty for potential gaps in the alignment. We denote the
number of nodes in a pathway as L. In this paper, we search for conserved pathways of size L = 16, 32, 64.
Based on the HMM framework [35,36], we transform the problem of “finding the best matching pair of
paths” to a problem of “finding the optimal pair of state sequences in the two HMMs” that jointly
maximize the observation probability of a virtual path (see Fig. 1). We use two different types of settings
for finding conserved pathways, where we do not allow gaps in the pathway alignment in one setting while
we allow gaps in the other setting. In general, the two setting will yield different predictions.
We can find the best matching pair of paths in the given networks using dynamic programming. For this
purpose, we first define the score for the most probable pair of a subsequence paths of length t (≤ L) as
follows:
γ(t, j, `) = max
i,k
[
γ(t− 1, i, k) + wh(ui, uj) + wm(vk, v`) + s(uj , v`)
]
. (3)
Next, we find the optimal pair of paths (u∗,v∗)
S(u∗,v∗) = max
u,v
[
S(u,v)
]
= max
j,`
γ(L, j, `), (4)
by computing the score (3) iteratively. As discussed in [35,36], we can add auxiliary states to the HMMs
that represent the PPI networks to find gapped path alignments. Instead of finding only the best matching
pair of paths, we can also search for the top k path pairs by replacing the max operator in (4) and (3) by
an operator that finds the k largest scores. The computational complexity of the described dynamic
programming algorithm is only O(kLM1M2) for finding the top k pairs of matching paths, where M1 is the
number of edges (i.e., interactions) in Gh, and M2 is the number of edges in Gm. Note that the
computational complexity is linear with respect to each parameter k, L, M1, and M2. To avoid multiple
occurrences of the same protein in the conserved pathways that are predicted by the algorithm, we
incorporate a “look-back” step into each iteration of the dynamic programming algorithm [36].
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Extraction of random pathways
In order to extract random pathways from the Homo sapiens PPI network, we performed random walks on
the network starting from a randomly selected node in network Gh. We randomly walk on the network to
choose a random pathway, until the size of the pathway reaches a pre-specified size L. During this random
walk, we avoid visiting a node that has been previously visited, so that the extracted random pathway
contains only distinct nodes.
Comparison between conserved pathways and random pathways
To compare the HIV-1 susceptibility of conserved pathways with that of random pathways, we computed
the following values: (1) The number of proteins within these pathways that have been predicted to be
intercepted by at least one of the HIV-1 proteins according to the human/HIV-1 interactome in [12]. (2)
The total number of predicted human/HIV-1 protein interactions within these pathways; (3) The average
HIV interaction scores within pathways. We also computed the p-values of the estimated results for
conserved pathways, according to the process described in the next subsection. Finally, for GO term
enrichment analysis, we used an open source software called the GO::TermFinder [39].
Computing p-values
In order to evaluate the statistical significance of the estimated results in conserved pathways, we first
extract a large number of random pathways (3, 000) from the Homo sapiens PPI network, based on
random walk. For each random pathway, we also estimate the indices of HIV-1 susceptibility (i.e., the
number of human proteins intercepted by HIV-1; the total number of human/HIV-1 interactions, the
average interaction scores among the proteins in each pathway). Baseline distributions of different indices
are estimated from these results. We can either model the baseline distributions using Gumbel
distributions [52] or simply use histograms. The latter approach was adopted in this paper. Once we have
estimated the baseline distributions, we can compute the p-values of the estimated results in conserved
pathways according to the estimated distributions.
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